Aquestive Therapeutics, Inc. SEC filings AQST

Aquestive Therapeutics, Inc. has 686 filings in SEC EDGAR's recent list, going back to May 14, 2007. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Aquestive Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Nov 5, 2026 Nov 5, 2026
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 3, 2026 Nov 3, 2026
8-K Current report
Bylaw or fiscal year change
Oct 19, 2026 Oct 15, 2026
8-K Current report
Regulation FD disclosure
Oct 15, 2026 Oct 15, 2026
8-K Current report
Material agreement
Oct 14, 2026 Oct 13, 2026
8-K Current report
Officer or director change
Sep 29, 2026 Sep 29, 2026
8-K Current report
Regulation FD disclosure
Sep 25, 2026 Sep 23, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 17, 2026 Sep 14, 2026
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 11, 2026 Aug 11, 2026
8-K Current report
Regulation FD disclosure, Other events
Aug 10, 2026 Aug 10, 2026
424B3 Prospectus Jul 9, 2026 —
EFFECT Filing Jul 8, 2026 —
S-3 Shelf registration Jun 26, 2026 —
8-K Current report
Shareholder vote results
Jun 10, 2026 Jun 10, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Material agreement, Agreement ended, Results of operations, New debt, Unregistered share sale, Regulation FD disclosure
May 13, 2026 May 12, 2026
ARS Annual report to shareholders Apr 24, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Jun 10, 2026
8-K Current report
Regulation FD disclosure
Mar 30, 2026 Mar 30, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 20, 2026 Mar 16, 2026
S-8 Employee stock plan registration Mar 4, 2026 —
10-K Annual report Mar 4, 2026 Dec 31, 2025
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
Mar 4, 2026 Mar 3, 2026
8-K Current report
Regulation FD disclosure
Feb 26, 2026 Feb 26, 2026
8-K Current report
Regulation FD disclosure
Feb 2, 2026 Jan 30, 2026
S-8 Employee stock plan registration Jan 21, 2026 —
8-K Current report
Other events
Jan 9, 2026 Jan 9, 2026
8-K Current report
Regulation FD disclosure
Nov 6, 2025 Nov 6, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2025 Nov 5, 2025
8-K Current report
Other events
Oct 8, 2025 Oct 8, 2025
8-K Current report
Regulation FD disclosure
Oct 1, 2025 Oct 1, 2025
8-K Current report
Regulation FD disclosure
Sep 8, 2025 Sep 8, 2025
8-K Current report
Regulation FD disclosure
Sep 4, 2025 Sep 4, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Aug 15, 2025 Aug 14, 2025
424B5 Prospectus supplement Aug 14, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Aug 14, 2025 Aug 13, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 11, 2025 Aug 11, 2025
8-K Current report
Other events
Jul 15, 2025 Jul 15, 2025
8-K Current report
Regulation FD disclosure
Jun 16, 2025 Jun 13, 2025
8-K Current report
Shareholder vote results
Jun 11, 2025 Jun 11, 2025
8-K Current report
Regulation FD disclosure
Jun 2, 2025 Jun 2, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 12, 2025 May 12, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 11, 2025
8-K Current report
Regulation FD disclosure
Apr 1, 2025 Apr 1, 2025
8-K Current report
Regulation FD disclosure
Mar 10, 2025 Mar 10, 2025
10-K Annual report Mar 5, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Mar 5, 2025 Mar 5, 2025
8-K Current report
Other events
Feb 12, 2025 Feb 12, 2025
S-8 Employee stock plan registration Jan 24, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
8-K Current report
Other events
Dec 19, 2024 Dec 19, 2024
8-K Current report
Regulation FD disclosure, Other events
Dec 2, 2024 Dec 2, 2024
8-K Current report
Officer or director change
Nov 7, 2024 Nov 1, 2024
8-K Current report
Regulation FD disclosure
Nov 6, 2024 Nov 6, 2024
10-Q Quarterly report Nov 4, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 4, 2024 Nov 4, 2024
8-K Current report
Other events
Oct 25, 2024 Oct 25, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 24, 2024 Oct 24, 2024
8-K Current report
Bylaw or fiscal year change
Oct 16, 2024 Oct 16, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 27, 2024 Sep 27, 2024
8-K Current report
Regulation FD disclosure
Sep 9, 2024 Sep 9, 2024
8-K Current report
Other events
Aug 14, 2024 Aug 14, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 6, 2024 Aug 6, 2024
8-K Current report
Regulation FD disclosure, Other events
Jul 25, 2024 Jul 25, 2024
8-K Current report
Shareholder vote results
Jun 21, 2024 Jun 20, 2024
8-K Current report
Regulation FD disclosure
Jun 7, 2024 Jun 6, 2024
8-K Current report
Officer or director change
Jun 6, 2024 Jun 3, 2024
8-K Current report
Regulation FD disclosure
May 8, 2024 May 7, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 7, 2024 May 7, 2024
8-K Current report
Other events
Apr 29, 2024 Apr 26, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 20, 2024
424B2 Prospectus Apr 24, 2024 —
424B2 Prospectus Apr 24, 2024 —
EFFECT Filing Apr 23, 2024 —
8-K Current report
Other events
Apr 22, 2024 Apr 22, 2024
CORRESP Letter to the SEC Apr 19, 2024 —
CORRESP Letter to the SEC Apr 19, 2024 —
CORRESP Letter to the SEC Apr 16, 2024 —
UPLOAD Letter from the SEC Apr 8, 2024 —
S-3 Shelf registration Apr 3, 2024 —
8-K Current report
Officer or director change
Apr 1, 2024 Apr 1, 2024
8-K Current report
Material agreement, Other events
Mar 21, 2024 Mar 19, 2024
424B5 Prospectus supplement Mar 21, 2024 —
424B5 Prospectus supplement Mar 19, 2024 —
8-K Current report
Other events
Mar 15, 2024 Mar 14, 2024
10-K Annual report Mar 5, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Mar 5, 2024 Mar 5, 2024
S-8 Employee stock plan registration Feb 12, 2024 —
UPLOAD Letter from the SEC Dec 19, 2023 —
CORRESP Letter to the SEC Dec 13, 2023 —
8-K Current report
Regulation FD disclosure
Dec 8, 2023 Dec 7, 2023
8-K Current report
Other events
Dec 5, 2023 Dec 5, 2023
8-K Current report
Regulation FD disclosure
Nov 8, 2023 Nov 8, 2023
10-Q Quarterly report Nov 6, 2023 Sep 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 6, 2023 Nov 6, 2023
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Other events
Nov 2, 2023 Nov 1, 2023
UPLOAD Letter from the SEC Oct 27, 2023 —
8-K Current report
Other events
Oct 10, 2023 Oct 9, 2023
424B3 Prospectus Oct 2, 2023 —
EFFECT Filing Sep 29, 2023 —
CORRESP Letter to the SEC Sep 27, 2023 —
UPLOAD Letter from the SEC Sep 25, 2023 —
S-3 Shelf registration Sep 21, 2023 —
8-K Current report
Other events
Sep 20, 2023 Sep 20, 2023
8-K Current report
Regulation FD disclosure
Aug 11, 2023 Aug 11, 2023
S-8 Employee stock plan registration Aug 9, 2023 —
8-K Current report
Results of operations, Regulation FD disclosure
Aug 7, 2023 Aug 7, 2023
10-Q Quarterly report Aug 7, 2023 Jun 30, 2023
8-K Current report
Material agreement
Aug 2, 2023 Aug 1, 2023
8-K Current report
Regulation FD disclosure
Jul 27, 2023 Jul 27, 2023
8-K Current report
Regulation FD disclosure, Other events
Jun 29, 2023 Jun 29, 2023
8-K Current report
Shareholder vote results
Jun 23, 2023 Jun 23, 2023
8-K Current report
Regulation FD disclosure, Other events
May 31, 2023 May 31, 2023
10-Q Quarterly report May 2, 2023 Mar 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 2, 2023 May 2, 2023
ARS Annual report to shareholders May 2, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 21, 2023
PRE 14A Preliminary proxy statement Apr 18, 2023 Jun 21, 2023
8-K Current report
Other events
Apr 13, 2023 Apr 13, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 13, 2023
8-K Current report
Regulation FD disclosure
Mar 7, 2023 Mar 7, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Mar 7, 2023 Mar 7, 2023
8-K Current report
Material agreement
Mar 6, 2023 Mar 2, 2023
8-K Current report
Bylaw or fiscal year change
Feb 7, 2023 Feb 2, 2023
8-K Current report
Other events
Jan 24, 2023 Jan 6, 2023
S-8 Employee stock plan registration Jan 18, 2023 —
8-K Current report
Listing notice
Jan 3, 2023 Dec 30, 2022
8-K Current report
Other events
Dec 22, 2022 Dec 22, 2022
8-K Current report
Other events
Dec 20, 2022 Dec 20, 2022
8-K Current report
Other events
Nov 7, 2022 Nov 4, 2022
8-K Current report
Regulation FD disclosure
Nov 2, 2022 Nov 2, 2022
10-Q Quarterly report Nov 1, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 1, 2022 Nov 1, 2022
8-K Current report
Material agreement, Other events
Oct 27, 2022 Oct 26, 2022
8-K Current report
Other events
Oct 24, 2022 Oct 24, 2022
8-K Current report
Other events
Oct 11, 2022 Oct 11, 2022
8-K Current report
Material agreement, Other events
Sep 28, 2022 Sep 26, 2022
8-K Current report
Regulation FD disclosure, Other events
Sep 27, 2022 Sep 27, 2022
8-K Current report
Regulation FD disclosure, Other events
Sep 13, 2022 Sep 12, 2022
8-K Current report
Other events
Sep 7, 2022 Sep 7, 2022
424B5 Prospectus supplement Sep 7, 2022 —
8-K Current report
Other events
Aug 31, 2022 Aug 30, 2022
8-K Current report
Other events
Aug 24, 2022 Aug 23, 2022
8-K Current report
Unregistered share sale, Officer or director change, Other events
Aug 10, 2022 Aug 10, 2022
8-K Current report
Regulation FD disclosure
Aug 3, 2022 Aug 3, 2022
8-K Current report
Results of operations
Aug 2, 2022 Aug 2, 2022
10-Q Quarterly report Aug 2, 2022 Jun 30, 2022
8-K Current report
Officer or director change
Jul 19, 2022 Jul 15, 2022
8-K Current report
Listing notice
Jul 15, 2022 Jul 14, 2022
8-K Current report
Other events
Jul 11, 2022 Jul 11, 2022
8-K Current report
Shareholder vote results
Jun 24, 2022 Jun 22, 2022
8-K Current report
Regulation FD disclosure, Other events
Jun 16, 2022 Jun 15, 2022
8-K Current report
Material agreement, Other events
Jun 8, 2022 Jun 6, 2022
424B5 Prospectus supplement Jun 8, 2022 —
DEFA14A Additional proxy material May 23, 2022 —
8-K Current report
Officer or director change
May 17, 2022 May 17, 2022
8-K Current report
Material agreement, New debt
May 17, 2022 May 13, 2022
10-Q Quarterly report May 4, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 4, 2022 May 3, 2022
8-K Current report
Other events
May 3, 2022 May 3, 2022
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 22, 2022
8-K Current report
Material agreement, Regulation FD disclosure
Apr 13, 2022 Apr 12, 2022
424B5 Prospectus supplement Apr 13, 2022 —
8-K Current report
Results of operations
Mar 8, 2022 Mar 8, 2022
10-K Annual report Mar 8, 2022 Dec 31, 2021
8-K Current report
Material agreement, Other events
Mar 3, 2022 Mar 3, 2022
8-K Current report
Other events
Mar 1, 2022 Feb 28, 2022
8-K Current report
Other events
Feb 25, 2022 Feb 24, 2022
8-K Current report
Other events
Feb 25, 2022 Feb 25, 2022
8-K Current report
Regulation FD disclosure
Jan 10, 2022 Jan 10, 2022
S-8 Employee stock plan registration Jan 7, 2022 —
8-K Current report
Other events
Dec 21, 2021 Dec 20, 2021
8-K Current report
Other events
Dec 16, 2021 Dec 13, 2021
8-K Current report
Results of operations
Nov 2, 2021 Nov 2, 2021
10-Q Quarterly report Nov 2, 2021 Sep 30, 2021
8-K Current report
Regulation FD disclosure, Other events
Oct 25, 2021 Oct 25, 2021
8-K Current report
Material agreement, New debt
Oct 8, 2021 Oct 7, 2021
8-K Current report
Material agreement, New debt
Oct 6, 2021 Sep 30, 2021
CT ORDER Filing Sep 22, 2021 —
8-K Current report
Regulation FD disclosure
Sep 13, 2021 Sep 13, 2021
8-K Current report
Material agreement, New debt
Aug 9, 2021 Aug 9, 2021
10-Q Quarterly report Aug 3, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 3, 2021 Aug 3, 2021
8-K Current report
Material agreement
Jul 30, 2021 Jul 28, 2021
8-K Current report
Other events
Jul 21, 2021 Jul 19, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AQST (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Warren, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1398733
Former names
MonoSol Rx, Inc. (until Mar 27, 2008)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.